R. Michael Carruthers, Chief Financial Officer at Edgewise Therapeutics, Inc. (EWTX), sold 1,336 shares at $8.90 ($12K) on 2023-05-02, disclosed to the SEC on 2023-05-03.
Open-market sale of $12k EWTX by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| EWTX | SELL | 2024-09-24 | $5.7M | — | Filing → |
| EWTX | SELL | 2024-05-03 | $41K | — | Filing → |
| EWTX | SELL | 2024-01-25 | $1.4M | — | Filing → |